Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Novotna

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Neurology|September 28, 2020
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple SclerosisMartina Novotna, Ales Tvaroh, Jan Mares
Reproductive Toxicology (Elmsford, N.Y.)|July 29, 2004
P-glycoprotein expression and distribution in the rat placenta during pregnancyMartina Novotna, Antonin Libra, Martin Kopecky, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2004
Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidinePetr Pavek, Gracia Merino, Els Wagenaar, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123Petr Pavek, Frantisek Staud, Zdenek Fendrich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Age is a critical determinant in recovery from multiple sclerosis relapsesBrittani L Conway, Burcu Zeydan, Uğur Uygunoğlu, et al.
Neurology|November 16, 2014
Relapses and disability accumulation in progressive multiple sclerosisM Mateo Paz Soldán, Martina Novotna, Nuhad Abou Zeid, et al.
Scientific Reports|June 28, 2016
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controlsJun Chen, Nicholas Chia, Krishna R Kalari, et al.
Neurology|July 26, 2015
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosisMartina Novotna, M Mateo Paz Soldán, Nuhad Abou Zeid, et al.
Multiple Sclerosis and Related Disorders|July 8, 2022
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infectionDominika Stastna, Ingrid Menkyova, Jiri Drahota, et al.
Multiple Sclerosis and Related Disorders|February 16, 2023
Corrigendum to 'To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection'[Multiple sclerosis and related disorders vol. 65 (2022) 104014]Dominika Stastna, Ingrid Menkyova, Jiri Drahota, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Neurology|September 28, 2020
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple SclerosisMartina Novotna, Ales Tvaroh, Jan Mares
Reproductive Toxicology (Elmsford, N.Y.)|July 29, 2004
P-glycoprotein expression and distribution in the rat placenta during pregnancyMartina Novotna, Antonin Libra, Martin Kopecky, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2004
Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidinePetr Pavek, Gracia Merino, Els Wagenaar, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123Petr Pavek, Frantisek Staud, Zdenek Fendrich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Age is a critical determinant in recovery from multiple sclerosis relapsesBrittani L Conway, Burcu Zeydan, Uğur Uygunoğlu, et al.
Neurology|November 16, 2014
Relapses and disability accumulation in progressive multiple sclerosisM Mateo Paz Soldán, Martina Novotna, Nuhad Abou Zeid, et al.
Scientific Reports|June 28, 2016
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controlsJun Chen, Nicholas Chia, Krishna R Kalari, et al.
Neurology|July 26, 2015
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosisMartina Novotna, M Mateo Paz Soldán, Nuhad Abou Zeid, et al.
Multiple Sclerosis and Related Disorders|July 8, 2022
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infectionDominika Stastna, Ingrid Menkyova, Jiri Drahota, et al.
Multiple Sclerosis and Related Disorders|February 16, 2023
Corrigendum to 'To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection'[Multiple sclerosis and related disorders vol. 65 (2022) 104014]Dominika Stastna, Ingrid Menkyova, Jiri Drahota, et al.
Pageof 1